4.6 Article

Host non-inflammatory neutrophils mediate the engraftment of bioengineered vascular networks

期刊

NATURE BIOMEDICAL ENGINEERING
卷 1, 期 6, 页码 -

出版社

NATURE RESEARCH
DOI: 10.1038/s41551-017-0081

关键词

-

资金

  1. Core Facility of the Dana-Farber/Harvard Cancer Center [P30 CA06516]
  2. National Institutes of Health [R00EB009096, R01AR069038, R01HL128452, R21AI123883]

向作者/读者索取更多资源

Notwithstanding the remarkable progress in vascular network engineering, implanted bioengineered microvessels mostly fail to form anastomoses with the host vasculature. Here we demonstrate that implants containing assembled human vascular networks (A-grafts) fail to engraft owing to their inability to engage non-inflammatory host neutrophils upon implantation into mice. By contrast, unassembled vascular cells (U-grafts) readily engage alternatively polarized neutrophils, which in turn serve as indispensable mediators of vascular assembly and anastomosis. The depletion of host neutrophils abrogated vascularization in U-grafts, whereas an adoptive transfer of neutrophils fully restored vascularization in myeloid-depleted mice. Neutrophil engagement was regulated by secreted factors and was progressively silenced as the vasculature matured. Exogenous addition of factors from U-grafts re-engaged neutrophils and enhanced revascularization in A-grafts, a process that was recapitulated by blocking Notch signalling. Our data suggest that the pro-vascularization potential of neutrophils can be harnessed to improve the engraftment of bioengineered tissues.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Endocrinology & Metabolism

Experimental models of Barth syndrome

William T. Pu

Summary: The passage discusses how mutation of the gene Tafazzin (TAZ) causes Barth syndrome, characterized by cardiomyopathy, skeletal muscle weakness, and neutropenia, due to TAZ's role in remodeling cardiolipin. Various model systems have been established to study the impact of cardiolipin remodeling on mitochondrial function and the pathogenesis of Barth syndrome, each contributing to a better understanding of TAZ function and the disease's pathophysiology.

JOURNAL OF INHERITED METABOLIC DISEASE (2022)

Review Endocrinology & Metabolism

Current and future treatment approaches for Barth syndrome

Reid Thompson, John Jefferies, Suya Wang, William T. Pu, Clifford Takemoto, Brittany Hornby, Andrea Heyman, Michael T. Chin, Hilary J. Vernon

Summary: Barth Syndrome is a genetic disorder caused by pathogenic variants in the TAFAZZIN gene, which results in symptoms affecting the heart, neutrophils, growth, and skeletal muscles. Current treatment focuses on symptom management and clinical trials are exploring new treatments targeting the mitochondrial pathology of the disease. Future treatments may include enzyme and gene therapies to directly target the defective TAFAZZIN pathway.

JOURNAL OF INHERITED METABOLIC DISEASE (2022)

Article Hematology

A new murine model of Barth syndrome neutropenia links TAFAZZIN deficiency to increased ER stress-induced apoptosis

Jihee Sohn, Jelena Milosevic, Thomas Brouse, Najihah Aziz, Jenna Elkhoury, Suya Wang, Alexander Hauschild, Nick van Gastel, Murat Cetinbas, Sara F. Tufa, Douglas R. Keene, Ruslan Sadreyev, William T. Pu, David B. Sykes

Summary: Barth syndrome is an X-linked disorder that causes cardiomyopathy, skeletal myopathy, and neutropenia. In this study, the researchers investigated potential mechanisms of neutropenia in Barth syndrome. They found that TAFAZZIN-deficient neutrophil progenitors showed increased sensitivity to apoptosis triggers and upregulation of markers of endoplasmic reticulum stress. However, there were no significant differences in neutrophil development or function. These findings provide a foundation for further research.

BLOOD ADVANCES (2022)

Article Cardiac & Cardiovascular Systems

Ryanodine receptor 2 (RYR2) dysfunction activates the unfolded protein response and perturbs cardiomyocyte maturation

Yuxuan Guo, Yangpo Cao, Blake D. Jardin, Xiaoran Zhang, Pingzhu Zhou, Silvia Guatimosim, Junsen Lin, Zhan Chen, Yueyang Zhang, Neil Mazumdar, Fujian Lu, Qing Ma, Yao-Wei Lu, Mingming Zhao, Da-Zhi Wang, Erdan Dong, William T. Pu

Summary: The aim of this study is to investigate the role of RYR2 in cardiomyocyte maturation. The researchers used genetic editing techniques to knockout RYR2 and found that its depletion led to structural and transcriptional defects in cardiomyocytes, along with activation of ER stress pathways. The defects in RYR2-depleted cardiomyocytes were partially rescued by an ER stress alleviator.

CARDIOVASCULAR RESEARCH (2023)

Letter Cardiac & Cardiovascular Systems

Efficient In Vivo Homology-Directed Repair Within Cardiomyocytes

Yanjiang Zheng, Nathan J. VanDusen, Catalina E. Butler, Qing Ma, Justin S. King, William T. Pu

CIRCULATION (2022)

Article Neurosciences

Endocannabinoid signaling in oligodendroglia

Eduardo Molina-Holgado, Pedro F. Esteban, Angel Arevalo-Martin, Rafael Moreno-Luna, Francisco Molina-Holgado, Daniel Garcia-Ovejero

Summary: Oligodendrocytes in the central nervous system synthesize myelin and have the ability to regulate their functions through interactions with other cells and sensing the environment. They respond to various signals, including the endocannabinoid signaling, which has therapeutic potential for promoting remyelination in central nervous system pathologies.
Article Biochemistry & Molecular Biology

The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo

Lucia Beltran-Camacho, Sara Eslava-Alcon, Marta Rojas-Torres, Daniel Sanchez-Morillo, Ma Pilar Martinez-Nicolas, Victoria Martin-Bermejo, Ines Garcia de la Torre, Esther Berrocoso, Juan Antonio Moreno, Rafael Moreno-Luna, Ma Carmen Duran-Ruiz

Summary: This study evaluated the impact of serum from asymptomatic COVID-19 individuals on circulating angiogenic cells (CACs) using a proteomics-based quantitative approach. The results confirmed that SARS-CoV-2 infection in asymptomatic individuals caused protein level changes related to coagulation and inflammatory processes. Additionally, certain proteins were up-regulated only in CACs treated with serum from asymptomatic patients during the highest peak of infection. These findings provide insight into the effects of SARS-CoV-2 infection and the development of potential treatment methods.

MOLECULAR MEDICINE (2022)

Article Cell Biology

Post-COVID Complications after Pressure Ulcer Surgery in Patients with Spinal Cord Injury Associate with Creatine Kinase Upregulation in Adipose Tissue

Mario Martinez-Torija, Pedro F. Esteban, Francisco Javier Espino-Rodriguez, Beatriz Paniagua-Torija, Eduardo Molina-Holgado, Silvia Ceruelo, Gemma Barroso-Garcia, Alba G. Arandilla, Luis F. Lopez-Almodovar, Angel Arevalo-Martin, Juan Antonio Moreno, Daniel Garcia-Ovejero, M. Carmen Duran-Ruiz, Rafael Moreno-Luna

Summary: The risk of complications following surgical procedures is significantly increased in patients with SARS-CoV-2 infection. This study found that SCI patients with a COVID-19-positive diagnosis showed worse recovery and severe postoperative complications. Proteomic analysis revealed several upregulated proteins in the adipose tissue surrounding the ulcers. Among them, CKMT2 and CKM stood out and increased after the COVID-19 diagnosis. These proteins were largely found in MGCs within the adipose tissue. The presence of CKMT2, CKM, and MGCs may serve as predictive biomarkers of postsurgical complications in post-COVID patients.
Article Cell Biology

ACTN2 Mutant Causes Proteopathy in Human iPSC-Derived Cardiomyocytes

Antonia T. L. Zech, Maksymilian Prondzynski, Sonia R. Singh, Niels Pietsch, Ellen Orthey, Erda Alizoti, Josefine Busch, Alexandra Madsen, Charlotta S. Behrens, Moritz Meyer-Jens, Giulia Mearini, Marc D. Lemoine, Elisabeth Kraemer, Diogo Mosqueira, Sanamjeet Virdi, Daniela Indenbirken, Maren Depke, Manuela Gesell Salazar, Uwe Voelker, Ingke Braren, William T. Pu, Thomas Eschenhagen, Elke Hammer, Saskia Schlossarek, Lucie Carrier

Summary: This study evaluated the impact of ACTN2 gene variants on cardiomyocyte structure and function. The results showed that the variants led to abnormal cellular phenotypes, including multinucleation, protein aggregation, hypertrophy, and myofibrillar disarray. Additionally, the variants activated proteolytic systems and impaired cardiac force. This study highlights the cellular pathology caused by ACTN2 gene variants and its importance in understanding ACTN2-associated cardiomyopathies.
Editorial Material Biotechnology & Applied Microbiology

Future Directions and Resource Needs for National Heart, Lung, and Blood Institute (NHLBI) Gene Therapy Research: A Report of an NHLBI Workshop

Cheryl L. McDonald, Pankaj Qasba, Daniel G. Anderson, Gang Bao, Richard A. Colvin, Donald B. Kohn, Punam Malik, Michael J. Mitchell, William T. Pu, David J. Rawlings, David A. Williams, Terence R. Flotte

HUMAN GENE THERAPY (2023)

Article Biochemistry & Molecular Biology

Genetic modifiers modulate phenotypic expression of tafazzin deficiency in a mouse model of Barth syndrome

Suya Wang, Erika Yazawa, Erin M. Keating, Neil Mazumdar, Alexander Hauschild, Qing Ma, Haiyan Wu, Yang Xu, Xu Shi, Douglas Strathdee, Robert E. Gerszten, Michael Schlame, William T. Pu

Summary: Barth syndrome is an X-linked disorder caused by loss-of-function mutations in Tafazzin (TAZ). Genetic modifiers strongly influence the phenotypic expression of Taz inactivation.

HUMAN MOLECULAR GENETICS (2023)

Article Biochemistry & Molecular Biology

Cardiovascular-related proteomic changes in ECFCs exposed to the serum of COVID-19 patients

Lucia Beltran-Camacho, Santosh D. Bhosale, Daniel Sanchez-Morillo, Ismael Sanchez-Gomar, Marta Rojas-Torres, Sara Eslava-Alcon, Mario Martinez-Torija, M. Angeles Ruiz de Infante, M. Dolores Nieto-Martin, Manuel A. Rodriguez-Iglesias, Juan A. Moreno, Esther Berrocoso, Martin R. Larsen, Rafael Moreno-Luna, M. Carmen Duran-Ruiz

Summary: SARS-CoV-2 infection affects the cardiovascular system, causing vascular damage and thromboembolic events. Endothelial dysfunction is an early response to COVID-19, which may lead to cardiovascular complications and long-term sequelae. However, the molecular mechanisms involved in these processes remain poorly understood.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2023)

Article Medicine, Research & Experimental

Yap1 modulates cardiomyocyte hypertrophy via impaired mitochondrial biogenesis in response to chronic mechanical stress overload

Peng Yue, Yue Zhang, Lei Liu, Kaiyu Zhou, Shutao Xia, Mou Peng, Hualin Yan, Xiaoqiang Tang, Zhan Chen, Donghui Zhang, Junling Guo, William T. Pu, Yuxuan Guo, Yimin Hua, Yifei Li

Summary: This study identified YAP signaling as a therapeutic target for pressure overload-induced heart diseases. The activation of YAP1 is associated with pathological hypertrophy, and its specific deletion in cardiomyocytes attenuates hypertrophy. Overexpression of YAP1 can replicate pressure overload-induced hypertrophy, and its activation leads to perturbation of mitochondria ultrastructure and function, as well as the repression of mitochondria dynamics regulators Dnm1l and Mfn1.

THERANOSTICS (2022)

Meeting Abstract Cardiac & Cardiovascular Systems

Selectively Expressing Sars-Cov-2 Spike Protein S1 Subunit In Cardiomyocytes Induces Cardiac Hypertrophy In Mice

Caroline Sheldon, Steven Negron, Chase W. Kessinger, Bing Xu, William T. Pu, Chieh-Yu Lin, Zhiqiang Lin

CIRCULATION RESEARCH (2022)

Meeting Abstract Cardiac & Cardiovascular Systems

Single Cell Duplex Sequencing in Cardiomyocytes Deciphers the Mutational Burden, DNA Damage, and Repair Mechanisms in Hypoxia-Induced Heart Muscle Cells

Nazia Hilal, Maksymilian K. Prondzynski, Sarah Araten, Guanlan Dong, Huang Yue, Michael Trembley, Indu Sivankutty, Christopher Walsh, Ming H. Chen, William T. Pu, Eunjung Alice Lee, Sangita Choudhury

CIRCULATION RESEARCH (2022)

暂无数据